Tag: RCE

Recce Pharmaceuticals antibiotics ASX RCE kidney urinary tract infection

Recce Pharmaceuticals’ new class antibiotic effective in treating urinary tract infections during pre-clinical trials

Frequent urinary tract infection (UTI) and kidney infection sufferers may have some relief after Recce Pharmaceuticals (ASX: RCE) revealed pre-clinical trials had demonstrated its...
Recce Pharmaceuticals ASX RCE synthetic antibiotic superbug US patent

Recce Pharmaceuticals locks-in US patent for synthetic antibiotic to target growing superbug problem

Recce Pharmaceuticals (ASX: RCE) has locked-in a US patent for its broad-spectrum synthetic antibiotics, paving the way for the company to shoulder into the...
Recce Pharmaceuticals ASX RCE research development rebate antibiotic

Recce Pharmaceuticals adds R&D rebate to its coffers

Recce Pharmaceuticals (ASX: RCE) has confirmed it has received an extra A$861,590 from the Australian Government for its overseas Advanced Drug Development expenditure in...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS